3,4-Methylenedioxy-N-propargylamphetamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

MDPL, also known as 3,4-methylenedioxy-N-propargylamphetamine or as N-propargyl-MDA, is a lesser-known drug and a substituted amphetamine.[1]

Other names3,4-Methylenedioxy-N-propargylamphetamine; MDPL; N-Propargyl-MDA
Routes of
administrationOral[1]
ATC code
  • None
Duration of actionUnknown[1]
Quick facts Clinical data, Other names ...
MDPL
Clinical data
Other names3,4-Methylenedioxy-N-propargylamphetamine; MDPL; N-Propargyl-MDA
Routes of
administration		Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • N-[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl]prop-2-yn-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H15NO2
Molar mass217.268 g·mol−1
3D model (JSmol)
  • CC(NCC#C)Cc1ccc2OCOc2c1
  • InChI=1S/C13H15NO2/c1-3-6-14-10(2)7-11-4-5-12-13(8-11)16-9-15-12/h1,4-5,8,10,14H,6-7,9H2,2H3
  • Key:LRYUTPIBTLEDJJ-UHFFFAOYSA-N
Close

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDPL's minimum dose as 150 mg orally and its duration as unknown.[1] MDPL causes few to no effects.[1]

Chemistry

Synthesis

The chemical synthesis of MDPL has been described.[1]

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

References

External links

Related Articles

Wikiwand AI